Interestingly, miR-29a has also been reported to upregulate the Hippo pathway through the relief of DNMT3B-mediated LATS1 methylation in HCC, thus interfering with YAP expression [53], and potentially with the YAP-mediated HNF4α downregulation [54]. Here, DNMT3B is linked to hepatocellular carcinoma.